Schonfeld Strategic Advisors LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 50 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$972,140
-0.6%
94,843
-2.6%
0.01%
+12.5%
Q4 2022$978,428
+2.0%
97,3560.0%0.01%0.0%
Q3 2022$959,000
+97.3%
97,356
+95.2%
0.01%
+60.0%
Q2 2022$486,00049,8810.01%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2023
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 503,834$4,907,0000.75%
683 Capital Management, LLC 1,199,000$11,678,0000.62%
Atalaya Capital Management LP 500,000$4,880,0000.52%
MMCAP International Inc. SPC 800,000$7,792,0000.46%
Kepos Capital LP 500,000$4,870,0000.36%
CANTOR FITZGERALD, L. P. 489,286$4,768,0000.36%
ANGELO GORDON & CO., L.P. 300,000$2,922,0000.33%
SPRING CREEK CAPITAL LLC 800,000$7,808,0000.31%
FIR TREE CAPITAL MANAGEMENT LP 1,000,503$9,765,0000.27%
DG Capital Management, LLC 127,665$1,246,0000.25%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders